Coppell Advisory Solutions »

Oncocyte Corporation shares owned by Coppell Advisory Solutions

Quarter-by-quarter ownership of Oncocyte Corporation (OCX) shares owned by Coppell Advisory Solutions from 13F filings

Historical chart of Coppell Advisory Solutions investment in Oncocyte Corporation

Tip: Access up to 7 years of quarterly data

All positions including Oncocyte Corporation held by Coppell Advisory Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Oncocyte Corporation by Coppell Advisory Solutions

Quarter filed Position value Share count Share price at filing
2023-12-31 $25 10 2.50

More positions owned by Coppell Advisory Solutions

First Tr Exchange Traded Fd Iv First Tr Enh New Etf FTSM (FTSM)
First Tr Exchange Traded Fd Vi Tcw Opportunis Etf Fixd (FIXD)
Microsoft Corp MSFT (MSFT)
Apple Aapl (AAPL)
Jp Morgan Chase & Co JPM (JPM)
Kingsmen Resources Ord KNG (KNG)
Spdr Series Trust Spdr Bloomberg Etf Bil (BIL)
Broadcom Avgo (AVGO)
Ishares Trust Short Treas Bd Etf SHV (SHV)
First Trust Large Cap Value Al Com Shs Etf Fta (FTA)
Ishares Trust Core S&p500 Etf Ivv (IVV)
First Trust Exchange-traded Fu Cap Strength Etf FTCS (FTCS)
Vaneck Vectors Etf Trust Invt Grade Fltg Etf FLTR (FLTR)
Vanguard S&p 500 Etf Voo (VOO)
First Tst Value Li Shs Etf FVD (FVD)

View all positions for Coppell Advisory Solutions

Top funds holding Oncocyte Corporation

Pura Vida Investments
Vanguard Group
Morgan Stanley
Geode Capital Management
BlackRock
Tower Research Capital
UBS Group
Pnc Financial Services
Bank of America Corporation
Jpmorgan Chase & Co
Nbc Securities
Advisor Group Holdings
Royal Bank of Canada
Wells Fargo & Company
Riggs Asset Managment

View all funds holding Oncocyte Corporation